Absorption, Distribution, Excretion and Effects on Drug Metabolizing Enzyme Activities of a New Antiplatelet Drug, Ethyl 2-(4,5-bis(4-methoxyphenyl)thiazol-2-yl)pyrrol-1-ylacetate(KBT-3022), after Multiple Oral Administration in Mice.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.